Study details
Enrolling now
Continuous Glucose Monitoring in People With Gastroparesis and Diabetes
Samita Garg
NCT IDNCT06046833ClinicalTrials.gov data as of Apr 2026
Target enrollment
50
Study length
about 2.2 years
Ages
18+
Locations
1 site in OH
What this study is about
This trial is testing a continuous glucose monitor (FreeStyle Libre 3 sensor) to see if it helps manage blood sugar levels in people with gastroparesis and diabetes. Participants will also receive nutritional drinks as part of the treatment.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Nutritional drink
- 2.Use FreeStyle Libre 3 continuous glucose monitoring sensor
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
All receive treatment
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Devices
monitoring
Body systems
Endocrinology